Tapewire

NYSE · USD

UNH

UNITEDHEALTH GROUP INC

Export transactions ↓
Tapewire entity
2809
SEC CIK
0000731766
Parsed reports
3,134

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 27, 2011 Filed Oct 28, 2011 21:00 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
SaleCommon Stock 650,000 $49.21 $31,988,775.00
Disclosure

SEC source: 0001209191-11-053161 · doc4.xml · nonDerivative · entry 4

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,614,535.705

F2 · price: This transaction was executed in multiple trades ranging from $49.00 to $49.64 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 27, 2011 Filed Oct 28, 2011 21:00 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionCommon Stock 650,000 $25.09 $16,310,125.00
Disclosure

SEC source: 0001209191-11-053161 · doc4.xml · nonDerivative · entry 3

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,264,535.705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2011 Filed Oct 28, 2011 21:00 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionNon-qualified stock option (right to buy) · Derivative 550,000 $0.00 Strike: $25.09 $0.00
Disclosure

SEC source: 0001209191-11-053161 · doc4.xml · derivative · entry 6

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Stock · 550,000 shares

Expires 2012-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options vested at a rate of 25% annually on January 7 from the years 2003 through 2006.

Read SEC document
October 26, 2011 Filed Oct 28, 2011 21:00 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
SaleCommon Stock 550,000 $49.00 $26,952,035.00
Disclosure

SEC source: 0001209191-11-053161 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,614,535.705

F1 · price: This transaction was executed in multiple trades ranging from $48.77 to $49.15 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 26, 2011 Filed Oct 28, 2011 21:00 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Exercise / conversionCommon Stock 550,000 $25.09 $13,800,875.00
Disclosure

SEC source: 0001209191-11-053161 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,164,535.705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:34 UTC Exercise / conversionNon-qualified stock option (right to buy) · Derivative 10,000 $0.00 Strike: $17.07 $0.00
Disclosure

SEC source: 0001209191-11-052742 · doc4.xml · derivative · entry 3

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2012-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:34 UTC SaleCommon Stock 10,000 $49.00 $489,998.00
Disclosure

SEC source: 0001209191-11-052742 · doc4.xml · nonDerivative · entry 2

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

F1 · price: This transaction was executed in multiple trades ranging from $48.99 to $49.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:34 UTC Exercise / conversionCommon Stock 10,000 $17.61 $176,050.00
Disclosure

SEC source: 0001209191-11-052742 · doc4.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:35 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Exercise / conversionNon-qualified stock option (right to buy) · Derivative 120,000 $0.00 Strike: $22.11 $0.00
Disclosure

SEC source: 0001209191-11-052744 · doc4.xml · derivative · entry 6

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 120,000 shares

Expires 2012-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options vested at a rate of 25% annually on January 7 from the years 2003 through 2006.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:35 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Exercise / conversionNon-qualified stock option (right to buy) · Derivative 50,000 $0.00 Strike: $18.24 $0.00
Disclosure

SEC source: 0001209191-11-052744 · doc4.xml · derivative · entry 5

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2012-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options vest at a rate of 25% annually on August 5 from the years 2003 through 2006.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:35 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
SaleCommon Stock 170,000 $48.75 $8,287,500.00
Disclosure

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,209.815

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:35 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Exercise / conversionCommon Stock 120,000 $22.11 $2,653,200.00
Disclosure

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,209.815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2011 Filed Oct 26, 2011 20:35 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Exercise / conversionCommon Stock 50,000 $18.24 $911,900.00
Disclosure

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,209.815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 24, 2011 Filed Oct 26, 2011 20:35 UTC
Sweere LoriEVP, Human Capital
Exercise / conversionStock Appreciation Right · Derivative 14,140 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0001209191-11-052745 · doc4.xml · derivative · entry 4

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,280

Underlying: Common Stock · 14,140 shares

Expires 2019-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

Read SEC document
October 24, 2011 Filed Oct 26, 2011 20:35 UTC
Sweere LoriEVP, Human Capital
SaleCommon Stock 3,073 $48.99 $150,558.25
Disclosure

SEC source: 0001209191-11-052745 · doc4.xml · nonDerivative · entry 3

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,085.795

F1 · price: This transaction was executed in multiple trades ranging from $48.99 to $49.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 24, 2011 Filed Oct 26, 2011 20:35 UTC
Sweere LoriEVP, Human Capital
Tax withholdingCommon Stock 11,067 $49.03 $542,615.01
Disclosure

SEC source: 0001209191-11-052745 · doc4.xml · nonDerivative · entry 2

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,158.795

Read SEC document
October 24, 2011 Filed Oct 26, 2011 20:35 UTC
Sweere LoriEVP, Human Capital
Exercise / conversionCommon Stock 14,140 $29.74 $420,523.60
Disclosure

SEC source: 0001209191-11-052745 · doc4.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,225.795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 21, 2011 Filed Oct 21, 2011 22:00 UTC SaleCommon Stock 100,000 $47.75 $4,775,080.00
Disclosure

SEC source: 0001209191-11-052407 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,508,970

F1 · price: This transaction was executed in multiple trades ranging from $47.70 to $47.90 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:24 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050696 · doc4.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:24 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050697 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,608,970

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:25 UTC GrantCommon Stock 1,602 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050698 · doc4.xml · nonDerivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,123

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:25 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050699 · doc4.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,420

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:26 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050700 · doc4.xml · nonDerivative · entry 1

LAWSON RODGER A · CIK 0001187442 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,373

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:26 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050701 · doc4.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 899,915

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:27 UTC GrantCommon Stock 1,602 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050702 · doc4.xml · nonDerivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,823

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:27 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050704 · doc4.xml · nonDerivative · entry 1

Shine Kenneth Irwin · CIK 0001455025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,976

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:28 UTC GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-050707 · doc4.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,890

F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:22 UTC GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048780 · doc4.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,126

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:22 UTC GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048781 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,608,096

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:23 UTC GrantCommon Stock 48 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048782 · doc4.xml · nonDerivative · entry 1

DARRETTA ROBERT J · CIK 0001188999 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,521

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:24 UTC GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048783 · doc4.xml · nonDerivative · entry 1

HOOPER MICHELE J · CIK 0001201723 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,546

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:24 UTC GrantCommon Stock 26 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048785 · doc4.xml · nonDerivative · entry 1

LAWSON RODGER A · CIK 0001187442 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,499

F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:25 UTC GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048786 · doc4.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 899,041

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:25 UTC GrantCommon Stock 48 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048787 · doc4.xml · nonDerivative · entry 1

RENWICK GLENN M · CIK 0001198119 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,221

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:26 UTC GrantCommon Stock 37 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048788 · doc4.xml · nonDerivative · entry 1

Shine Kenneth Irwin · CIK 0001455025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,102

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:27 UTC GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048789 · doc4.xml · nonDerivative · entry 1

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,016

F1 · shares: Represents dividend equivalents paid on vested deferred stock units.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:27 UTC
BAER RICHARD NEVP & Chief Legal Officer
GrantCommon Stock 144.189 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048790 · doc4.xml · nonDerivative · entry 1

BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,744.189

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:27 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
GrantCommon Stock 384.459 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048791 · doc4.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,769.604

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:28 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
GrantCommon Stock 283.285 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048793 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,614,535.705

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:28 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
GrantCommon Stock 182.113 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048794 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,209.815

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:29 UTC
RANGEN ERIC SSr VP & Chief Acctg Officer
GrantCommon Stock 40.469 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048795 · doc4.xml · nonDerivative · entry 2

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,963.109

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:29 UTC
RENFRO LARRY CEVP, UnitedHealth Group
GrantCommon Stock 384.459 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048796 · doc4.xml · nonDerivative · entry 2

RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,911.604

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:30 UTC
Sweere LoriEVP, Human Capital
GrantCommon Stock 80.938 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048797 · doc4.xml · nonDerivative · entry 2

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,085.795

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:30 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
GrantCommon Stock 80.938 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048798 · doc4.xml · nonDerivative · entry 2

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,926.915

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:31 UTC
WELTERS ANTHONYEVP, UnitedHealth Group
GrantCommon Stock 182.113 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048799 · doc4.xml · nonDerivative · entry 2

WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,656.281

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 21, 2011 Filed Sep 22, 2011 22:31 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
GrantCommon Stock 384.459 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-048800 · doc4.xml · nonDerivative · entry 2

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,786.604

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

Read SEC document
September 19, 2011 Filed Sep 20, 2011 20:20 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.73 $0.00
Disclosure

SEC source: 0001209191-11-048516 · doc4.xml · derivative · entry 3

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2011-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2011 Filed Sep 20, 2011 20:20 UTC Exercise / conversionCommon Stock 10,000 $16.73 $167,250.00
Disclosure

SEC source: 0001209191-11-048516 · doc4.xml · nonDerivative · entry 1

BURKE RICHARD T · CIK 0000905023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,608,065

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 02, 2011 Filed Aug 4, 2011 20:49 UTC
BAER RICHARD NEVP & Chief Legal Officer
GrantNon-Qualified Stock Options (right to buy) · Derivative 63,800 $0.00 Strike: $46.98 $0.00
Disclosure

SEC source: 0001209191-11-042488 · doc4.xml · derivative · entry 2

BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,800

Underlying: Common Stock · 63,800 shares

Expires 2021-08-02

F3 · derivative.exercise_date: The stock options vest at a rate of 25% annually on August 2 from the years 2012 through 2015.

Read SEC document
August 02, 2011 Filed Aug 4, 2011 20:49 UTC
BAER RICHARD NEVP & Chief Legal Officer
GrantCommon Stock 42,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-11-042488 · doc4.xml · nonDerivative · entry 1

BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,600

F1 · shares: The restricted stock units will vest at a rate of 25% annually on August 2 from the years 2012 through 2015.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on August 2, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period (January 1, 2011 to December 31, 2013) and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics previously approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 21,300.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.